Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 9985 to 9996 of 44081 entries
Sorted by: Best Match Show Resources per page
Usefulness of semiquantitative PCR-Invader assay for selecting candidates for daclatasvir plus asunaprevir combination therapy among patients with hepatitis C virus genotype 1b.

Hepatology research : the official journal of the Japan Society of Hepatology

Honda K, Seike M, Oribe J, Endo M, Arakawa M, Tokoro M, Iwao M, Mori T, Nishimura J, Takahashi Y, Omori K, Yamashita T, Muro T, Murakami K.
PMID: 29080280
Hepatol Res. 2018 Mar;48(4):255-263. doi: 10.1111/hepr.12994. Epub 2017 Nov 27.

AIMS: PCR-Invader is a highly sensitive assay for detecting non-structural protein 5A (NS5A) resistance-associated variants (RAVs) of hepatitis C virus (HCV). Here, we validated the accuracy of the semiquantitative PCR-Invader (SQ-PI) assay compared to direct sequencing (DS) for identifying...

Cite
Honda K, Seike M, Oribe J, et al. Usefulness of semiquantitative PCR-Invader assay for selecting candidates for daclatasvir plus asunaprevir combination therapy among patients with hepatitis C virus genotype 1b. Hepatol Res. 2017;48(4):255-263doi: 10.1111/hepr.12994.
Honda, K., Seike, M., Oribe, J., Endo, M., Arakawa, M., Tokoro, M., Iwao, M., Mori, T., Nishimura, J., Takahashi, Y., Omori, K., Yamashita, T., Muro, T., & Murakami, K. (2018). Usefulness of semiquantitative PCR-Invader assay for selecting candidates for daclatasvir plus asunaprevir combination therapy among patients with hepatitis C virus genotype 1b. Hepatology research : the official journal of the Japan Society of Hepatology, 48(4), 255-263. https://doi.org/10.1111/hepr.12994
Honda, Koichi, et al. "Usefulness of semiquantitative PCR-Invader assay for selecting candidates for daclatasvir plus asunaprevir combination therapy among patients with hepatitis C virus genotype 1b." Hepatology research : the official journal of the Japan Society of Hepatology vol. 48,4 (2018): 255-263. doi: https://doi.org/10.1111/hepr.12994
Honda K, Seike M, Oribe J, Endo M, Arakawa M, Tokoro M, Iwao M, Mori T, Nishimura J, Takahashi Y, Omori K, Yamashita T, Muro T, Murakami K. Usefulness of semiquantitative PCR-Invader assay for selecting candidates for daclatasvir plus asunaprevir combination therapy among patients with hepatitis C virus genotype 1b. Hepatol Res. 2018 Mar;48(4):255-263. doi: 10.1111/hepr.12994. Epub 2017 Nov 27. PMID: 29080280.
Copy Download .nbib Format: NLM
Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon?.

World journal of hepatology

Butt AS, Sharif F, Abid S.
PMID: 29527262
World J Hepatol. 2018 Feb 27;10(2):267-276. doi: 10.4254/wjh.v10.i2.267.

Hepatocellular carcinoma (HCC) is a major cause of morbidity and mortality worldwide. Chronic hepatitis C virus infection (HCV) is the most common cause of HCC in many European countries, Japan and Pakistan. Introduction of the new direct acting antivirals...

Cite
Butt AS, Sharif F, Abid S. Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon?. World J Hepatol. 2018;10(2):267-276doi: 10.4254/wjh.v10.i2.267.
Butt, A. S., Sharif, F., & Abid, S. (2018). Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon?. World journal of hepatology, 10(2), 267-276. https://doi.org/10.4254/wjh.v10.i2.267
Butt, Amna Subhan, et al. "Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon?." World journal of hepatology vol. 10,2 (2018): 267-276. doi: https://doi.org/10.4254/wjh.v10.i2.267
Butt AS, Sharif F, Abid S. Impact of direct acting antivirals on occurrence and recurrence of hepatocellular carcinoma: Biologically plausible or an epiphenomenon?. World J Hepatol. 2018 Feb 27;10(2):267-276. doi: 10.4254/wjh.v10.i2.267. PMID: 29527262; PMCID: PMC5838445.
Copy Download .nbib Format: NLM
Colorectal tumor prevention by the progestin medroxyprogesterone acetate is critically dependent on postmenopausal status.

Oncotarget

Meijer BJ, Wielenga MCB, Hoyer PB, Amos-Landgraf JM, Hakvoort TBM, Muncan V, Heijmans J, van den Brink GR.
PMID: 30093969
Oncotarget. 2018 Jul 17;9(55):30561-30567. doi: 10.18632/oncotarget.25703. eCollection 2018 Jul 17.

The large randomized placebo controlled trials of the Women's Health Initiative have shown that the combination of estrogen and progestin medroxyprogesterone acetate (MPA) protects from colorectal cancer in postmenopausal women. No effect was observed in women treated with estrogen...

Cite
Meijer BJ, Wielenga MCB, Hoyer PB, et al. Colorectal tumor prevention by the progestin medroxyprogesterone acetate is critically dependent on postmenopausal status. Oncotarget. 2018;9(55):30561-30567doi: 10.18632/oncotarget.25703.
Meijer, B. J., Wielenga, M. C. B., Hoyer, P. B., Amos-Landgraf, J. M., Hakvoort, T. B. M., Muncan, V., Heijmans, J., & van den Brink, G. R. (2018). Colorectal tumor prevention by the progestin medroxyprogesterone acetate is critically dependent on postmenopausal status. Oncotarget, 9(55), 30561-30567. https://doi.org/10.18632/oncotarget.25703
Meijer, Bartolomeus J, et al. "Colorectal tumor prevention by the progestin medroxyprogesterone acetate is critically dependent on postmenopausal status." Oncotarget vol. 9,55 (2018): 30561-30567. doi: https://doi.org/10.18632/oncotarget.25703
Meijer BJ, Wielenga MCB, Hoyer PB, Amos-Landgraf JM, Hakvoort TBM, Muncan V, Heijmans J, van den Brink GR. Colorectal tumor prevention by the progestin medroxyprogesterone acetate is critically dependent on postmenopausal status. Oncotarget. 2018 Jul 17;9(55):30561-30567. doi: 10.18632/oncotarget.25703. eCollection 2018 Jul 17. PMID: 30093969; PMCID: PMC6078141.
Copy Download .nbib Format: NLM
Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review.

World journal of hepatology

Shizuma T.
PMID: 29527261
World J Hepatol. 2018 Feb 27;10(2):254-266. doi: 10.4254/wjh.v10.i2.254.

Spontaneous bacterial (SBP) and spontaneous fungal peritonitis (SFP) can be a life-threatening infection in patients with liver cirrhosis (LC) and ascites. One of the possible mechanisms of developing SBP is bacterial translocation. Although the number of polymorphonuclear cells in...

Cite
Shizuma T. Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review. World J Hepatol. 2018;10(2):254-266doi: 10.4254/wjh.v10.i2.254.
Shizuma, T. (2018). Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review. World journal of hepatology, 10(2), 254-266. https://doi.org/10.4254/wjh.v10.i2.254
Shizuma, Toru. "Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review." World journal of hepatology vol. 10,2 (2018): 254-266. doi: https://doi.org/10.4254/wjh.v10.i2.254
Shizuma T. Spontaneous bacterial and fungal peritonitis in patients with liver cirrhosis: A literature review. World J Hepatol. 2018 Feb 27;10(2):254-266. doi: 10.4254/wjh.v10.i2.254. PMID: 29527261; PMCID: PMC5838444.
Copy Download .nbib Format: NLM
Statin use and the risk of .

Infection and drug resistance

Tariq R, Mukhija D, Gupta A, Singh S, Pardi DS, Khanna S.
PMID: 29559802
Infect Drug Resist. 2018 Mar 13;11:405-416. doi: 10.2147/IDR.S156475. eCollection 2018.

PURPOSE: Statins have pleiotropic effects beyond cholesterol lowering by immune modulation. The association of statins with primary PATIENTS AND METHODS: We searched MEDLINE, Embase, and Web of Science from January 1978 to December 2016 for studies assessing the association...

Cite
Tariq R, Mukhija D, Gupta A, et al. Statin use and the risk of . Infect Drug Resist. 2018;11:405-416doi: 10.2147/IDR.S156475.
Tariq, R., Mukhija, D., Gupta, A., Singh, S., Pardi, D. S., & Khanna, S. (2018). Statin use and the risk of . Infection and drug resistance, 11405-416. https://doi.org/10.2147/IDR.S156475
Tariq, Raseen, et al. "Statin use and the risk of ." Infection and drug resistance vol. 11 (2018): 405-416. doi: https://doi.org/10.2147/IDR.S156475
Tariq R, Mukhija D, Gupta A, Singh S, Pardi DS, Khanna S. Statin use and the risk of . Infect Drug Resist. 2018 Mar 13;11:405-416. doi: 10.2147/IDR.S156475. eCollection 2018. PMID: 29559802; PMCID: PMC5856044.
Copy Download .nbib Format: NLM
[No title available]

Frontiers in microbiology

Miftahussurur M, Nusi IA, Graham DY, Yamaoka Y.
PMID: 28642748
Front Microbiol. 2017 Jun 08;8:1034. doi: 10.3389/fmicb.2017.01034. eCollection 2017.

The hygiene hypothesis links environmental and microbial exposures in early life to the prevalence of atopy, allergy, and asthma.

Cite
Miftahussurur M, Nusi IA, Graham DY, et al. . Front Microbiol. 2017;8:1034doi: 10.3389/fmicb.2017.01034.
Miftahussurur, M., Nusi, I. A., Graham, D. Y., & Yamaoka, Y. (2017). . Frontiers in microbiology, 81034. https://doi.org/10.3389/fmicb.2017.01034
Miftahussurur, Muhammad, et al. "." Frontiers in microbiology vol. 8 (2017): 1034. doi: https://doi.org/10.3389/fmicb.2017.01034
Miftahussurur M, Nusi IA, Graham DY, Yamaoka Y. . Front Microbiol. 2017 Jun 08;8:1034. doi: 10.3389/fmicb.2017.01034. eCollection 2017. PMID: 28642748; PMCID: PMC5462935.
Copy Download .nbib Format: NLM
Occurrence of late relapse of hepatitis C virus confirmed by molecular analysis after sustained virologic response to interferon-ribavirin-based therapy.

Hepatology research : the official journal of the Japan Society of Hepatology

Hayashi K, Ishigami M, Yasuda S, Ishizu Y, Kuzuya T, Honda T, Ishikawa T, Hirooka Y, Goto H.
PMID: 28643404
Hepatol Res. 2018 Feb;48(3):E78-E86. doi: 10.1111/hepr.12929. Epub 2017 Jul 29.

AIM: The optimal duration of follow-up for patients who achieve sustained virologic responses (SVR) has become an important issue. Reports on long-term follow-up of SVR have indicated that 99% of patients maintained SVR. However, the limitations of a majority...

Cite
Hayashi K, Ishigami M, Yasuda S, et al. Occurrence of late relapse of hepatitis C virus confirmed by molecular analysis after sustained virologic response to interferon-ribavirin-based therapy. Hepatol Res. 2017;48(3):E78-E86doi: 10.1111/hepr.12929.
Hayashi, K., Ishigami, M., Yasuda, S., Ishizu, Y., Kuzuya, T., Honda, T., Ishikawa, T., Hirooka, Y., & Goto, H. (2018). Occurrence of late relapse of hepatitis C virus confirmed by molecular analysis after sustained virologic response to interferon-ribavirin-based therapy. Hepatology research : the official journal of the Japan Society of Hepatology, 48(3), E78-E86. https://doi.org/10.1111/hepr.12929
Hayashi, Kazuhiko, et al. "Occurrence of late relapse of hepatitis C virus confirmed by molecular analysis after sustained virologic response to interferon-ribavirin-based therapy." Hepatology research : the official journal of the Japan Society of Hepatology vol. 48,3 (2018): E78-E86. doi: https://doi.org/10.1111/hepr.12929
Hayashi K, Ishigami M, Yasuda S, Ishizu Y, Kuzuya T, Honda T, Ishikawa T, Hirooka Y, Goto H. Occurrence of late relapse of hepatitis C virus confirmed by molecular analysis after sustained virologic response to interferon-ribavirin-based therapy. Hepatol Res. 2018 Feb;48(3):E78-E86. doi: 10.1111/hepr.12929. Epub 2017 Jul 29. PMID: 28643404.
Copy Download .nbib Format: NLM
Alpha-1 antitrypsin deficiency: a novel cause of isolated systolic resistant hypertension?.

Journal of hypertension

Van Leeuw JB, Berra E, Gu Y, Petit T, Lacroix V, Lanthier N, Van Hoof M, Staessen JA, Persu A.
PMID: 27270187
J Hypertens. 2016 Aug;34(8):1659-61. doi: 10.1097/HJH.0000000000000997.

No abstract available.

Cite
Van Leeuw JB, Berra E, Gu Y, et al. Alpha-1 antitrypsin deficiency: a novel cause of isolated systolic resistant hypertension?. J Hypertens. 2016;34(8):1659-61doi: 10.1097/HJH.0000000000000997.
Van Leeuw, J. B., Berra, E., Gu, Y., Petit, T., Lacroix, V., Lanthier, N., Van Hoof, M., Staessen, J. A., & Persu, A. (2016). Alpha-1 antitrypsin deficiency: a novel cause of isolated systolic resistant hypertension?. Journal of hypertension, 34(8), 1659-61. https://doi.org/10.1097/HJH.0000000000000997
Van Leeuw, Jean-Baudouin, et al. "Alpha-1 antitrypsin deficiency: a novel cause of isolated systolic resistant hypertension?." Journal of hypertension vol. 34,8 (2016): 1659-61. doi: https://doi.org/10.1097/HJH.0000000000000997
Van Leeuw JB, Berra E, Gu Y, Petit T, Lacroix V, Lanthier N, Van Hoof M, Staessen JA, Persu A. Alpha-1 antitrypsin deficiency: a novel cause of isolated systolic resistant hypertension?. J Hypertens. 2016 Aug;34(8):1659-61. doi: 10.1097/HJH.0000000000000997. PMID: 27270187.
Copy Download .nbib Format: NLM
Serrated Colorectal Lesions in Patients With Inflammatory Bowel Disease.

Gastroenterology & hepatology

Parian AM, Lazarev MG.
PMID: 29491757
Gastroenterol Hepatol (N Y). 2018 Jan;14(1):19-25.

The serrated neoplasia pathway is thought to account for up to 30% of sporadic colorectal cancer, but its role in inflammatory bowel disease (IBD)-related colorectal cancer is still not well elucidated. Hyperplastic polyps are not thought to impart an...

Cite
Parian AM, Lazarev MG. Serrated Colorectal Lesions in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2018;14(1):19-25
Parian, A. M., & Lazarev, M. G. (2018). Serrated Colorectal Lesions in Patients With Inflammatory Bowel Disease. Gastroenterology & hepatology, 14(1), 19-25.
Parian, Alyssa M, and Lazarev, Mark G. "Serrated Colorectal Lesions in Patients With Inflammatory Bowel Disease." Gastroenterology & hepatology vol. 14,1 (2018): 19-25.
Parian AM, Lazarev MG. Serrated Colorectal Lesions in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2018 Jan;14(1):19-25. PMID: 29491757; PMCID: PMC5824591.
Copy Download .nbib Format: NLM
Hepatitis B Virus Infection and Organ Transplantation.

Gastroenterology & hepatology

Ayoub WS, Martin P, Bhamidimarri KR.
PMID: 29491759
Gastroenterol Hepatol (N Y). 2018 Jan;14(1):33-40.

Hepatitis B virus (HBV) infection remains an important cause of liver disease and continues to present several unique challenges in organ transplantation despite the availability of an effective vaccine to prevent HBV infection and the introduction of oral therapy...

Cite
Ayoub WS, Martin P, Bhamidimarri KR. Hepatitis B Virus Infection and Organ Transplantation. Gastroenterol Hepatol (N Y). 2018;14(1):33-40
Ayoub, W. S., Martin, P., & Bhamidimarri, K. R. (2018). Hepatitis B Virus Infection and Organ Transplantation. Gastroenterology & hepatology, 14(1), 33-40.
Ayoub, Walid S, et al. "Hepatitis B Virus Infection and Organ Transplantation." Gastroenterology & hepatology vol. 14,1 (2018): 33-40.
Ayoub WS, Martin P, Bhamidimarri KR. Hepatitis B Virus Infection and Organ Transplantation. Gastroenterol Hepatol (N Y). 2018 Jan;14(1):33-40. PMID: 29491759; PMCID: PMC5824593.
Copy Download .nbib Format: NLM
Correction.

Hepatology (Baltimore, Md.)

[No authors listed]
PMID: 28114740
Hepatology. 2017 Feb;65(2):760. doi: 10.1002/hep.28996. Epub 2017 Jan 10.

No abstract available.

Cite
Correction. Hepatology. 2017;65(2):760doi: 10.1002/hep.28996.
(2017). Correction. Hepatology (Baltimore, Md.), 65(2), 760. https://doi.org/10.1002/hep.28996
"Correction." Hepatology (Baltimore, Md.) vol. 65,2 (2017): 760. doi: https://doi.org/10.1002/hep.28996
Correction. Hepatology. 2017 Feb;65(2):760. doi: 10.1002/hep.28996. Epub 2017 Jan 10. PMID: 28114740.
Copy Download .nbib Format: NLM
Pain Management in Patients With Inflammatory Bowel Disease.

Gastroenterology & hepatology

Szigethy E.
PMID: 29491764
Gastroenterol Hepatol (N Y). 2018 Jan;14(1):53-56.

No abstract available.

Cite
Szigethy E. Pain Management in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2018;14(1):53-56
Szigethy, E. (2018). Pain Management in Patients With Inflammatory Bowel Disease. Gastroenterology & hepatology, 14(1), 53-56.
Szigethy, Eva. "Pain Management in Patients With Inflammatory Bowel Disease." Gastroenterology & hepatology vol. 14,1 (2018): 53-56.
Szigethy E. Pain Management in Patients With Inflammatory Bowel Disease. Gastroenterol Hepatol (N Y). 2018 Jan;14(1):53-56. PMID: 29491764; PMCID: PMC5824598.
Copy Download .nbib Format: NLM
Showing 9985 to 9996 of 44081 entries